• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016年中国肺癌高峰论坛专家小组关于液体活检的共识。

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

作者信息

Wu Yi-Long, Wang Chang-Li, Sun Yan, Liao Mei-Lin, Guan Zhong-Zhen, Yang Zhi-Min, Zhou Qing-Hua, Lu Shun, Cheng Ying, Liu Xiao-Qing, Zhang Xu-Chao, Zhou Caicun, Wang Jie, Zhou Qing, Song Yong, Han Bao-Hui, Ma Zhi-Yong, Yang Fan, Wang Qun, Chuai Shao-Kun, Shao Yang, He Wei, Zhu Guanshan, Xiong Lei, Wang Jian-Jun, Chen Ke-Neng, Zhang Li, Mao Wei-Min, Ma Sheng-Lin, Feng Ji-Feng, Yang Xue-Ning, Xu Lin, Chen Gang, Zhao Jian, Song Qi-Bin, Shen-Tu Yang, Qiao Gui-Bin, Yu Ding, Yu Shi-Ying, Hu Yi, Chen Ming, Chen Gong-Yan, Fan Yun, Zhang He-Long, Liang Jun, Zhu Guang-Ying, Cui Jiu-Wei, Yang Jin-Ji, Zhao Qiong, Zhao Ming-Fang, Lu You, Chang Jian-Hua, Li Jun-Ling, Yang Yue, Hu Jie, Gu Chun-Dong, Zhang Yi-Chen, Zhong Wen-Zhao

机构信息

Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.

Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

出版信息

ESMO Open. 2017 Apr 4;2(Suppl 1):e000174. doi: 10.1136/esmoopen-2017-000174. eCollection 2017.

DOI:10.1136/esmoopen-2017-000174
PMID:28848676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5559904/
Abstract

The diagnosis and treatment of lung cancer have evolved into the era of precision medicine. Liquid biopsy, a minimally invasive approach, has emerged as a promising practice in genetic profiling and monitoring of lung cancer. Translating liquid biopsy from bench to bedside has encountered various challenges, including technique selection, protocol standardisation, data analysis and cost management. Regarding these challenges, the 2016 Chinese Lung Cancer Summit expert panel organised a trilateral forum involving oncologists, clinicians, clinical researchers, and industrial expertise on the 13th Chinese Lung Cancer Summit to formally discuss these controversies. Six consensuses were reached to guide the use of liquid biopsy and perform precision medicine in both clinic and research.

摘要

肺癌的诊断和治疗已进入精准医学时代。液体活检作为一种微创方法,已成为肺癌基因分析和监测中一种很有前景的手段。将液体活检从实验室应用到临床面临着各种挑战,包括技术选择、方案标准化、数据分析和成本管理。针对这些挑战,2016年中国肺癌高峰论坛专家小组在第十三届中国肺癌高峰论坛上组织了一次由肿瘤学家、临床医生、临床研究人员和行业专家参与的三边论坛,正式讨论这些争议问题。达成了六项共识,以指导液体活检的应用,并在临床和研究中开展精准医学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa4/5559904/9464b9d0f0aa/esmoopen-2017-000174f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa4/5559904/cc2596919651/esmoopen-2017-000174f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa4/5559904/9464b9d0f0aa/esmoopen-2017-000174f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa4/5559904/cc2596919651/esmoopen-2017-000174f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa4/5559904/9464b9d0f0aa/esmoopen-2017-000174f02.jpg

相似文献

1
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.2016年中国肺癌高峰论坛专家小组关于液体活检的共识。
ESMO Open. 2017 Apr 4;2(Suppl 1):e000174. doi: 10.1136/esmoopen-2017-000174. eCollection 2017.
2
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel.2017年中国肺癌高峰论坛专家小组关于免疫疗法的共识。
Transl Lung Cancer Res. 2018 Jun;7(3):428-436. doi: 10.21037/tlcr.2018.04.15.
3
[Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].[中国、日本和韩国胃肠道间质瘤诊断与治疗的异同:从专家共识到合作前景]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Sep 25;22(9):812-819. doi: 10.3760/cma.j.issn.1671-0274.2019.09.003.
4
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.游离DNA与下一代测序助力肺癌个性化医疗
Oncotarget. 2016 Oct 25;7(43):71013-71035. doi: 10.18632/oncotarget.11717.
5
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer.液体活检在非小细胞肺癌患者决策中的作用
J Clin Med. 2020 Nov 16;9(11):3674. doi: 10.3390/jcm9113674.
6
Precision medicine initiative-report of the 10th Lung Cancer Summit Forum for Chinese Directors of Thoracic Surgery and the 4th Summit Forum for Chinese Lung Cancer Collaborative Group (CLCCG).精准医学倡议——第十届中国胸外科主任肺癌高峰论坛暨中国肺癌协作组(CLCCG)第四届高峰论坛报告
J Thorac Dis. 2015 Aug;7(8):E258-61. doi: 10.3978/j.issn.2072-1439.2015.08.09.
7
Liquid biopsy for the detection and management of surgically resectable tumors.液体活检在可手术切除肿瘤的检测和管理中的应用。
Langenbecks Arch Surg. 2019 Aug;404(5):517-525. doi: 10.1007/s00423-019-01788-9. Epub 2019 Aug 5.
8
From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel.从肺癌的诊断到治疗:CT 检测到的肺结节的处理,2015 中德肺癌专家共识的总结。
Transl Lung Cancer Res. 2016 Aug;5(4):377-88. doi: 10.21037/tlcr.2016.07.09.
9
[Precise application of Traditional Chinese Medicine in minimally-invasive techniques].[中医在微创技术中的精准应用]
Zhongguo Gu Shang. 2018 Jun 25;31(6):493-496. doi: 10.3969/j.issn.1003-0034.2018.06.001.
10
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.液体活检:晚期非小细胞肺癌患者的一种潜在且有前景的诊断工具。
Indian J Cancer. 2017 Dec;54(Supplement):S25-S30. doi: 10.4103/ijc.IJC_514_17.

引用本文的文献

1
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.检测血浆 EGFR 突变以实现非病理诊断肺癌患者的个体化治疗。
Cancer Med. 2020 Mar;9(6):2085-2095. doi: 10.1002/cam4.2869. Epub 2020 Jan 28.
2
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.非小细胞肺癌的生物标志物:印度分子检测共识指南。
Adv Ther. 2019 Apr;36(4):766-785. doi: 10.1007/s12325-019-00903-y. Epub 2019 Mar 12.
3
Established, emerging and elusive molecular targets in the treatment of lung cancer.

本文引用的文献

1
Integrated digital error suppression for improved detection of circulating tumor DNA.用于改善循环肿瘤DNA检测的集成数字误差抑制
Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.
2
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.外泌体在非小细胞肺癌患者血清中的分离与鉴定是可行的:证据的批判性分析及其在临床实践中的潜在作用
Oncotarget. 2016 May 10;7(19):28748-60. doi: 10.18632/oncotarget.7638.
3
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
肺癌治疗中的既定、新兴和难以捉摸的分子靶点。
J Pathol. 2018 Apr;244(5):565-577. doi: 10.1002/path.5038. Epub 2018 Feb 14.
循环肿瘤细胞可识别接受根治性切除的非小细胞肺癌患者的早期复发情况。
PLoS One. 2016 Feb 25;11(2):e0148659. doi: 10.1371/journal.pone.0148659. eCollection 2016.
4
Clinical and biological significance of circulating tumor cells in cancer.循环肿瘤细胞在癌症中的临床及生物学意义
Mol Oncol. 2016 Mar;10(3):408-17. doi: 10.1016/j.molonc.2016.01.010. Epub 2016 Feb 10.
5
Liquid cancer biopsy: the future of cancer detection?液体癌症活检:癌症检测的未来?
Lancet Oncol. 2016 Feb;17(2):123. doi: 10.1016/S1470-2045(16)00016-4.
6
Functional studies on circulating and disseminated tumor cells in carcinoma patients.癌症患者循环及播散肿瘤细胞的功能研究
Mol Oncol. 2016 Mar;10(3):443-9. doi: 10.1016/j.molonc.2016.01.004. Epub 2016 Jan 18.
7
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.游离DNA包含一种体内核小体足迹,可告知其组织来源。
Cell. 2016 Jan 14;164(1-2):57-68. doi: 10.1016/j.cell.2015.11.050.
8
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.洛拉替尼的ALK耐药突变L1198F导致对克唑替尼重新致敏。
N Engl J Med. 2016 Jan 7;374(1):54-61. doi: 10.1056/NEJMoa1508887. Epub 2015 Dec 23.
9
Precision medicine--personalized, problematic, and promising.精准医学——个性化、存在问题且充满希望。
N Engl J Med. 2015 Jun 4;372(23):2229-34. doi: 10.1056/NEJMsb1503104. Epub 2015 May 27.
10
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.获得性表皮生长因子受体(EGFR)C797S突变介导携带EGFR T790M的非小细胞肺癌对AZD9291耐药。
Nat Med. 2015 Jun;21(6):560-2. doi: 10.1038/nm.3854. Epub 2015 May 4.